ArriVent BioPharma Standard Deviation
| AVBP Stock | | | 29.62 -0.21 -0.70% |
The Standard Deviation is a measure of how spread out the prices or returns of an asset are on average. It is the most widely used risk indicator in the field of investing and finance. Standard Deviation is commonly used to measure confidence in statistical conclusions regarding certain equity instruments or portfolios of equities. Below is ArriVent BioPharma's current Standard Deviation with peer comparisons and related risk metrics.
Current Standard Deviation Value
The Standard Deviation of 3.48 for ArriVent BioPharma indicates moderate price variability. This places ArriVent BioPharma within the typical volatility range for Stock.
Standard Deviation | = | SQRT(V) |
| = | 3.48 | |
Standard Deviation Peers Comparison
The peer group averages 7.0 for Standard Deviation, with ArriVent BioPharma at 3.48 falling below that level. Readings span 3.51 (Arvinas) to 12.35 (Replimune Group). ArriVent BioPharma has exhibited less price dispersion than the peer average over the measured period.
Standard Deviation Relative To Other Indicators
The chart below plots Standard Deviation against Maximum Drawdown for ArriVent BioPharma and its peers. Each point represents one equity — position along the horizontal axis shows Standard Deviation while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
ArriVent BioPharma's Standard Deviation reads
3.48 while Maximum Drawdown reads
18.15 , a
5.21 ratio between the two. This indicates Maximum Drawdown substantially exceeds Standard Deviation for ArriVent BioPharma.
Methodology, Assumptions & Data Sources
The current Standard Deviation for ArriVent BioPharma is 3.48. The Standard Deviation for ArriVent BioPharma applies a standardized calculation to daily closing prices and, where applicable, volume data across the selected period. All inputs are based on exchange-reported closing prices, with adjustments for stock splits, dividends, and other corporate actions. Indicator accuracy depends on data continuity across the calculation period. Gaps in trading history may affect the output.
Other Technical Indicators